Exercise-based cardiac rehabilitation for coronary heart disease

Keyphrases

• Confidence Interval 100%
• Coronary Artery Disease 100%
• Exercise-based Cardiac Rehabilitation 100%
• Risk Ratio 86%
• Myocardial Infarction 27%
• Large Reduction 22%
• All-cause Mortality 18%
• Coronary Artery Bypass Grafting 18%
• Percutaneous Coronary Intervention 18%
• All-cause Hospitalization 18%
• Health-related Quality of Life 13%
• Cochrane Review 13%
• Hospitalization Risk 13%
• Cardiovascular Hospitalizations 13%
• Cardiac Rehabilitation 13%
• Cardiovascular Mortality 9%
• Randomized Controlled Trial 9%
• Cost-effectiveness 9%
• Risk of Bias 9%
• Meta-regression 9%
• Rehabilitation Exercise 9%
• Exercise Control 9%
• Low-middle Income Countries 9%
• Cardiovascular Mortality Risk 9%
• Clinical Outcomes 4%
• Hospital Admission 4%
• Angina Pectoris 4%
• Short Form 36 (SF-36) 4%
• Risk Reduction 4%
• Follow-up Time 4%
• Cause of Death 4%
• Effect Modifier 4%
• Embase 4%
• Mortality Rate 4%
• Clinical Efficacy 4%
• Social Functioning 4%
• Exercise Effect 4%
• Living with 4%
• Exercise Training 4%
• MEDLINE 4%
• Extracted Data 4%
• Coronary Heart Disease Mortality 4%
• Potential Treatments 4%
• Psychosocial Intervention 4%
• General Health 4%
• Physical Functioning 4%
• Adult Women 4%
• Adult Men 4%
• Clinically Meaningful Difference 4%
• Revascularization 4%
• Educational Intervention 4%
• Trial Reporting 4%
• Number-needed-to-treat 4%
• Most Common Cause 4%
• Post-myocardial Infarction 4%
• Physical Performance 4%
• Cochrane 4%
• Quality of Life Outcomes 4%
• Short-term Follow-up 4%
• Beneficial Outcomes 4%
• Improved Health 4%
• Long Follow-up 4%
• Publication Year 4%
• Economic Evaluation 4%
• Clinical Trial Registry 4%
• Disease Case 4%
• Quality-adjusted Life Years 4%
• Health Care Costs 4%
• Generalisability 4%
• Support Needs 4%
• Usual Clinical Practice 4%
• Mental Health Measures 4%
• Mental Component 4%
• Medium-term Follow-up 4%
• Clinical Costs 4%
• Exercise Dose 4%
• New Trial 4%
• Rehabilitation Setting 4%
• Stratified Meta-analysis 4%
• Exercise-based Intervention 4%
• Bypass Grafts-coronary 4%
• Trial-based Economic Evaluation 4%
• Cost-effective Use of Resources 4%

Nursing and Health Professions

• Confidence Interval 100%
• Ischemic Heart Disease 100%
• Heart Rehabilitation 100%
• Heart Infarction 31%
• Quality of Life 18%
• All Cause Mortality 18%
• Percutaneous Coronary Intervention 18%
• Coronary Artery Bypass Graft 18%
• Cardiovascular Mortality 18%
• Cost Effectiveness Analysis 9%
• Clinical Outcome 4%
• Health Care Cost 4%
• Clinical Practice 4%
• Symptom 4%
• Short Form 36 4%
• Mortality Rate 4%
• Meta Analysis 4%
• Coronary Artery Disease 4%
• Sample Size 4%
• Revascularization 4%
• Angina Pectoris 4%
• Case Mix 4%
• Numbers Needed to Treat 4%
• Mental Health 4%
• Evaluation Study 4%
• Embase 4%
• Economic Evaluation 4%
• Clinical Effectiveness 4%
• Quality Adjusted Life Year 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Ischemic Heart Disease 100%
• Heart Infarction 63%
• All Cause Mortality 36%
• Cardiovascular Mortality 36%
• Randomized Controlled Trial 18%
• Population Study 9%
• Angina Pectoris 9%
• Symptom 9%
• Mortality Rate 9%
• Clinical Trial 9%
• Coronary Artery Disease 9%
• Case Mix 9%
• Number Needed to Treat 9%